Formulation Screening of Levetiracetam Sustained Release Tablets
Abstract
Objective: To prepare the sustained-release preparation of levetiracetam. Methods: The sustained-release materials were selected for wet granulation and tablet pressing, and the best formula was determined. Levetiracetam sustained-release tablets were prepared and the influencing factors were investigated. Results and Conclusions: The formulation was reasonable, the preparation process was simple, and the quality was stable.
Keywords
Levetiracetam; Sustained release tablets; Release; Stability
Full Text:
PDFReferences
Levetiracetam sustained release tablets (trade name Keppra XR)® FDA instructions.
Import registration standard of levetiracetam tablets jx20070146.
Usp38 levetiracetam sustained release tablets.
Quality standard for clinical trial application of levetiracetam API.
Release determination method of levetiracetam sustained release tablets published by FDA.
DOI: https://doi.org/10.12346/jnp.v2i1.6278
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Jing Zhou, Quanzhong Hu
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.